|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/10 | |||
| A61K 9/10 | |||
| A61K 9/14 | |||
| C07D 491/107 | |||
| A61K 31/517 | |||
| A61P 35/00 | |||
| A61P 27/02 |
| (11) | Patento numeris | 3062618 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14857737.2 |
| Europos patento paraiškos padavimo data | 2014-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/063444 |
| Data | 2014-10-31 |
| (87) | Numeris | WO 2015/066482 |
| Data | 2015-05-07 |
| (30) | Numeris | Data | Šalis |
| 201361898741 P | 2013-11-01 | US | |
| 201462039177 P | 2014-08-19 | US | |
| 201462039192 P | 2014-08-19 | US |
| (72) |
ENLOW, Elizabeth, US
NGUYEN, Minh Ngoc, US
ONG, Winston Z., US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
| CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |